Search
Search Results
##search.searchResults.foundPlural##
-
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
274PDF: 213Suppl. Files: 39HTML: 8 -
FUNGAL INFECTIONS OF THE EAR IN IMMUNOCOMPROMISED HOST: A REVIEW
3542PDF: 1362HTML: 3708Letter to Editor: 183 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7890PDF: 4086HTML: 7336 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1156PDF: 920HTML: 343 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2025PDF: 1852HTML: 340 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2160PDF: 1190HTML: 3702 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1335PDF: 806HTML: 1022Untitled: 183 -
-
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2132PDF: 1409HTML: 698 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1163PDF: 824HTML: 3352 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2377PDF: 1579HTML: 614 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2774PDF: 1112HTML: 11214 -
-
-
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
975PDF: 641Html: 154 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1390PDF: 489HTML: 3953 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
829PDF: 486HTML: 1300 -
PROPHYLAXIS OF MALARIA
2988PDF: 1014HTML: 17789Figures SChwartz: 159 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
996PDF: 585HTML: 72 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
961PDF: 530HTML: 720 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
812PDF: 536HTML: 4012 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
2906PDF: 1017HTML: 4578 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4760PDF: 1757HTML: 2701Untitled: 211 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1806PDF: 794HTML: 3597 -
-
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3277PDF: 1459HTML: 3995 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7396PDF: 2411HTML: 1720Table 1.: 204Table 2.: 215Table 3.: 195Table 4.: 195 -
How I treat acute and persistent sickle cell pain
1899PDF: 1110HTML: 477







